• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Allergan donates $1M for research fellows

Article

Irvine, CA-Allergan will donate $1 million over 2 years to academic medical institutions to support fellows researching glaucoma and corneal and retinal diseases.

Irvine, CA-Allergan will donate $1 million over 2 years to academic medical institutions to support fellows researching glaucoma and corneal and retinal diseases.

Ten initial Horizon Grants, announced Nov. 12, were selected from 65 applications and will be awarded to 13 ophthalmology programs (one grant is being shared by three programs between two therapeutic areas). These grants are intended to help fellows seeking to develop careers in academic medicine, particularly in the diagnosis or pharmacologic treatment of specific ocular diseases. Except in the case of the shared grant, recipients will receive about $40,000 each year for 2 years.

Recipients in the cornea area:

Retina specialist recipients:

Grants were awarded based on the strength of the fellowship program, the clinical and research plan for the institution's fellow, how the grant funds will be used, and activities in which the fellow will be engaged while in the program. About 10 more grants, which fund salary and research costs, will be awarded over the course of the 2-year program.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.